Publications

Add filters (0)

3 results

Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers.

January 1, 2022

Curr Opin Rheumatol

Abstract PURPOSE OF REVIEW Osteoarthritis (OA) is a painful disease for which drug development has proven difficult. One major reason for this is the heterogeneity of the disease and the current lack of operationalized means to distinguish various disease endotypes (molecular subtypes). Biomarkers measured in blood or urine, reflecting joint tissue turnover, have been developed […]

Read publication

Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes.

January 1, 2019

Curr Opin Rheumatol

Abstract PURPOSE OF REVIEW This review focuses on the molecular taxonomy of osteoarthritis from the perspective of molecular biomarkers. We discuss how wet biochemical markers may be used to understand disease pathogenesis and progression and define molecular endotypes of osteoarthritis and how these correspond to clinical phenotypes. RECENT FINDINGS Emerging evidence suggests that osteoarthritis is […]

Read publication

Development and use of biochemical markers in osteoarthritis: current update.

January 1, 2018

Curr Opin Rheumatol

Abstract PURPOSE OF REVIEW There is an increasing demand for noninvasive and descriptive biochemical markers (biomarkers) in osteoarthritis; for enabling early drug development (including translational research), evaluating clinical trial at an early stage and for subtyping. Purpose of the review is to review and comment on current availability of such biomarkers. RECENT FINDINGS Many different […]

Read publication